Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952
Bouwhuis, M.G, Suciu, S, Kruit, W, Salès, F, Stoitchkov, K, Patel, P, Cocquyt, V, Thomas, J, Liénard, D, Eggermont, A.M.M, Ghanem, G
Published in European journal of cancer (1990) (01.02.2011)
Published in European journal of cancer (1990) (01.02.2011)
Get full text
Journal Article
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B
Stoitchkov, K, Letellier, S, Garnier, J-P, Bousquet, B, Tsankov, N, Morel, P, Ghanem, G, Le Bricon, T
Published in Melanoma research (01.06.2002)
Published in Melanoma research (01.06.2002)
Get more information
Journal Article
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial
Eggermont, Alexander MM, Suciu, Stefan, MacKie, Rona, Ruka, Wlodzimierz, Testori, Alessandro, Kruit, Wim, Punt, Cornelis JA, Delauney, Michelle, Sales, François, Groenewegen, Gerard, Ruiter, Dirk J, Jagiello, Izabella, Stoitchkov, Konstantin, Keilholz, Ulrich, Lienard, Danielle
Published in The Lancet (British edition) (01.10.2005)
Published in The Lancet (British edition) (01.10.2005)
Get full text
Journal Article
Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio
Letellier, S, Garnier, J P, Spy, J, Stoitchkov, K, Le Bricon, T, Baccard, M, Revol, M, Kerneis, Y, Bousquet, B
Published in Melanoma research (01.08.1999)
Published in Melanoma research (01.08.1999)
Get more information
Journal Article
Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals
NAUMOVA, Elissaveta, MIHAYLOVA, Anastassia, STOITCHKOV, Konstantin, IVANOVA, Milena, QUIN, Ludmila, TONEVA, Miglena
Published in Cancer Immunology, Immunotherapy (01.02.2005)
Published in Cancer Immunology, Immunotherapy (01.02.2005)
Get full text
Journal Article
Prognostic value of autoantibodies (auto-AB) in melanoma patients (pts) in the EORTC 18952 trial of adjuvant interferon (IFN) compared to observation (obs)
Bouwhuis, M., Suciu, S., Kruit, W., Salès, F., Patel, P., Punt, C., Stoitchkov, K., Delaunay, M., ten Hagen, T., Eggermont, A. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Serum S-100B protein is a strong independent prognostic marker for distant-metastasis free survival (DMFS) in stage III melanoma patients: An evaluation of the EORTC randomized trial 18952 comparing IFNα versus observation
Suciu, S., Ghanem, G., Kruit, W., Stoitchkov, K., Patel, P., Delaunay, M., ten Hagen, T., Musat, E., Salès, F., Eggermont, A. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker
Stoitchkov, Konstantin, Letellier, Sabine, Garnier, Jean-Pierre, Bousquet, Bernard, Tsankov, Nikolai, Morel, Patrice, Ghanem, Ghanem, Le Bricon, Thierry
Published in Melanoma research (01.12.2003)
Published in Melanoma research (01.12.2003)
Get more information
Journal Article
Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma
Le Bricon, Thierry, Stoitchkov, Konstantin, Letellier, Sabine, Guibal, Fabien, Spy, Joelle, Garnier, Jean-Pierre, Bousquet, Bernard
Published in Clinica chimica acta (01.04.1999)
Published in Clinica chimica acta (01.04.1999)
Get full text
Journal Article
Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler™ system
Stoitchkov, Konstantin, Letellier, Sabine, Garnier, Jean-Pierre, Toneva, Miglena, Naumova, Elissaveta, Peytcheva, Ekaterina, Tzankov, Nikolai, Bousquet, Bernard, Morel, Patrice, Le Bricon, Thierry
Published in Clinica chimica acta (01.04.2001)
Published in Clinica chimica acta (01.04.2001)
Get full text
Journal Article
1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III
Eggermont, A.M.M., Suciu, S., Ruka, W., Testori, A., Kruit, W., Punt, C.J.A., Delaunay, M., Sales, F., Stoitchkov, K., Groenewegen, G., Mackie, R., Patel, P., Lienard, D.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article